﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Cision News</title><link>https://news.cision.com</link><description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description><pubDate>Tue, 09 Jun 2026 13:41:15 GMT</pubDate><image><title>Cision News</title><width>146</width><height>60</height><link>https://news.cision.com</link><url>https://news.cision.com/Content/img/news-logo.png</url></image><item><title>OxySure Therapeutics (OXYS) Provides Corporate Update</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--provides-corporate-update,c9957189</link><guid isPermaLink="false">cision2176703</guid><description><![CDATA[Frisco, Texas, USA, April 18, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions today provided a corporate update.

 

The Company announced that it had effected a reverse split of its common stock at a ratio of 1-for-50. The reverse split is subject to the Financial Industry Regulatory Authority (FINRA) declaring it effective. In addition, the Board of Directors made the]]></description><pubDate>Mon, 18 Apr 2016 12:30:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) Provides Stockholder Update</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--provides-stockholder-update,c9945856</link><guid isPermaLink="false">cision2159067</guid><description><![CDATA[Frisco, Texas, March 31, 2016 – OxySure Therapeutics, Inc. (OXYS) ("OxySure," or the "Company"), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its "oxygen from powder" technology and other innovative emergency medical solutions today provided a stockholder update.

The Company provided an updated advisory to stockholders indicating that it expects to file its audited financial statements for the fiscal year 2015 during the week of April 11, 2016.

The Company’s legal team also addressed a recent FDA safety notice regarding the]]></description><pubDate>Thu, 31 Mar 2016 12:00:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) to Host Shareholder Update Conference Call</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--to-host-shareholder-update-conference-call,c9934379</link><guid isPermaLink="false">cision2142752</guid><description><![CDATA[Frisco, Texas,March 15, 2016 – OxySure Therapeutics, Inc. (OXYS) ("OxySure," or the "Company"), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its "oxygen from powder" technology and other innovative emergency medical solutions today announced that the Company will be hosting an investor update conference call on Thursday, March 17, 2016 at 9:00am EST.

To join the OxySure Stockholder Update Call, please click the link below and dial the phone number five to ten minutes prior to the start of the conference call and enter your]]></description><pubDate>Tue, 15 Mar 2016 12:00:00 GMT</pubDate></item><item><title>BUYINS.NET Updates OxySure Therapeutics (OXYS) SqueezeTrigger Report</title><link>http://news.cision.com/oxysure-systems--inc-/r/buyins-net-updates-oxysure-therapeutics--oxys--squeezetrigger-report,c9933608</link><guid isPermaLink="false">cision2141392</guid><description><![CDATA[· Approximately 16.75 Million Shares Shorted Since June 2012
  · Short Squeeze Expected When Stock Crosses Above $0.47 SqueezeTrigger Price
FRISCO, TX--(Marketwired - March 14, 2016) - OxySure Therapeutics, Inc. (OXYS (http://finance.yahoo.com/q?s=oxys)) ("OxySure," or the "Company"), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its "oxygen from powder" technology and other innovative emergency medical solutions today announced BUYINS.NET,  (http://www.globenewswire.com/newsroom/ctr?d=190943&l=1&u=http%3A%2F%2Fwww.buyins.net)http://]]></description><pubDate>Mon, 14 Mar 2016 12:00:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) Launches New Cardiac Safety e-Commerce Website</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--launches-new-cardiac-safety-e-commerce-website,c9930533</link><guid isPermaLink="false">cision2136570</guid><description><![CDATA[Frisco, Texas, USA, March 8, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions today announced the launch a new cardiac safety e-commerce retail website.

The website is located at www.AED-Oxygen.com and allows for the quick and easy purchase and checkout of Automated External Defibrillators (AEDs), OxySure emergency oxygen devices and all related accessories and supplies.]]></description><pubDate>Tue, 08 Mar 2016 13:00:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) Launches “March Madness” Sales Competition</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--launches--march-madness--sales-competition,c9927739</link><guid isPermaLink="false">cision2131864</guid><description><![CDATA[Frisco, Texas, USA, March 2, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions today launched its first annual “March Madness” sales competition.

OxySure’s March Madness competition is nationwide and designed to encourage OxySure sales managers to redouble their March sales efforts and energy through vibrant and friendly competition. Throughout the month of March, sales]]></description><pubDate>Wed, 02 Mar 2016 13:00:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) Receives Fifth of Five Incentives from City of Frisco</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--receives-fifth-of-five-incentives-from-city-of-frisco,c9913774</link><guid isPermaLink="false">cision2112908</guid><description><![CDATA[Frisco, Texas, USA, February 16, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions today announces that the Company has received the fifth of five economic incentives from the City of Frisco through the Frisco Economic Development Corporation (“FEDC”).

The FEDC has provided OxySure a significant incentive over five years, designed to incentivize capital investment and job]]></description><pubDate>Tue, 16 Feb 2016 13:00:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) to Present at the RedChip Global Online Microcap Conference</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--to-present-at-the-redchip-global-online-microcap-conference,c9912166</link><guid isPermaLink="false">cision2108764</guid><description><![CDATA[Frisco, Texas, February 11, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions is scheduled to present at the RedChip Global Online Microcap Conference on Thursday, February 11, 2016, at 9:00 a.m. Eastern Time. The presentation can be viewed at www.RedChip.com. A live Q&A session will follow the investor presentation.

The RedChip Global Online Microcap Conference brings]]></description><pubDate>Thu, 11 Feb 2016 12:00:00 GMT</pubDate></item><item><title>OxySure (OXYS) Doubles Production Capacity in Response to Booming Backlog</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure--oxys--doubles-production-capacity-in-response-to-booming-backlog,c9911259</link><guid isPermaLink="false">cision2107216</guid><description><![CDATA[Frisco, Texas, February 10, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions today announced that the Company has doubled its production capacity in response to a rapidly increasing backlog.

Said Richard Bryant, OxySure’s Production Manager: “Through recent investments in infrastructure and additional manufacturing staff we were able to reduce our current backlog from two]]></description><pubDate>Wed, 10 Feb 2016 13:00:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) Establishes Supply Agreement with ORS Nasco, a Division of Essendant</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--establishes-supply-agreement-with-ors-nasco--a-division-of-essendant,c9907704</link><guid isPermaLink="false">cision2101971</guid><description><![CDATA[Frisco, Texas, February 4, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions today announced that the Company has established a supply agreement with ORS Nasco, a division of Essendant, a global distributor of workplace essentials with $5.4 billion in sales.

“This agreement allows us to offer additional, complimentary offerings to our institutional customers seeking a]]></description><pubDate>Thu, 04 Feb 2016 13:00:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) to Present at the 2nd Annual Innovations Investor Conference in Miami</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--to-present-at-the-2nd-annual-innovations-investor-conference-in-miami,c9905983</link><guid isPermaLink="false">cision2099350</guid><description><![CDATA[Unique Panel Discussion on “How Sports Can Enhance Your Business”
Frisco, Texas, February 2, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions today announced that the Company will be presenting at the second Annual Innovations Investor Conference in Miami, FL on Monday, February 22, 2016 at the Ritz-Carlton South Beach, presented by SeeThruEquity and The Brewer Group.

This]]></description><pubDate>Tue, 02 Feb 2016 13:00:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) Appoints Territory Sales Manager in South Florida</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--appoints-territory-sales-manager-in-south-florida,c9903708</link><guid isPermaLink="false">cision2096015</guid><description><![CDATA[Frisco, Texas, January 28, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions today announced that Edward C. Diaz was appointed to the position of Territory Sales Manager in South Florida.

“We are pleased to welcome Eddy to our growing national sales team and look forward to developing a solid base in South Florida,” stated Julian T. Ross, CEO of OxySure. “The Florida market]]></description><pubDate>Thu, 28 Jan 2016 13:30:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) Partners with MedOne Capital for Customer Medical Equipment Leasing</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--partners-with-medone-capital-for-customer-medical-equipment-leasing,c9902123</link><guid isPermaLink="false">cision2093742</guid><description><![CDATA[Frisco, Texas, January 26, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative medical solutions today announced that the Company has partnered with MedOne Capital, the premier leasing provider of medical equipment in the United States to provide OxySure customers easy, fast and flexible financing of medical devices.

Julian Ross, Chairman and CEO of OxySure stated: “We have already closed several deals]]></description><pubDate>Tue, 26 Jan 2016 13:30:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) Welcomes Dr. Zachariah P. Zachariah to Strategic Advisory Board</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--welcomes-dr--zachariah-p--zachariah-to-strategic-advisory-board,c9895106</link><guid isPermaLink="false">cision2082955</guid><description><![CDATA[Frisco, Texas, January 13, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative medical solutions today announced that Dr. Zachariah P. Zachariah, a former Director of Ivax Corporation (together with its Chairman Dr. Phil Frost) will be joining OxySure’s Strategic Advisory Board effective immediately. Ivax, a marketer of a patented asthma inhaler called Easi-Breathe and other branded respiratory drugs, was]]></description><pubDate>Wed, 13 Jan 2016 13:00:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) To Present At The 34th Annual J.P. Morgan Healthcare Conference</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--to-present-at-the-34th-annual-j-p--morgan-healthcare-conference,c9892183</link><guid isPermaLink="false">cision2078294</guid><description><![CDATA[Frisco, Texas, January 6, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative medical solutions will be presenting at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco. Mr. Julian Ross, Chairman and CEO will provide a corporate overview at 12:00 noon on Monday, January 11, 2016 at the SeeThruEquity Microcap Investor event at The Fairmont Hotel, 950 Mason Street, San Francisco, CA 94108.]]></description><pubDate>Wed, 06 Jan 2016 13:00:00 GMT</pubDate></item><item><title>OxySure Therapeutics (OXYS) Launches Cloud-based Device Tracking System</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-therapeutics--oxys--launches-cloud-based-device-tracking-system,c9880434</link><guid isPermaLink="false">cision2060533</guid><description><![CDATA[OxyTrac Allows Customers to be Legally Compliant and Rescue Ready
Frisco, Texas, December 8, 2015 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other innovative medical solutions, today launched OxyTracTM, a cloud based software system that allows customers to track all their Automated External Defibrillators (AEDs), OxySure units, and other device maintenance, renewals and incidents.

The OxyTrac system provides]]></description><pubDate>Tue, 08 Dec 2015 13:00:00 GMT</pubDate></item><item><title>OxySure Systems, Inc. (OXYS) Completes Name Change to OxySure Therapeutics, Inc.</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure-systems--inc---oxys--completes-name-change-to-oxysure-therapeutics--inc-,c9877511</link><guid isPermaLink="false">cision2055796</guid><description><![CDATA[Frisco, Texas, December 2, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other innovative medical solutions, today announced the completion of its name change to OxySure Therapeutics, Inc.

Julian Ross, CEO of OxySure reiterated that “the purpose of the name change is to better reflect the business and industry that the Company operates in.” Ross also reminded stakeholders that “the name change also enhances the]]></description><pubDate>Wed, 02 Dec 2015 13:00:00 GMT</pubDate></item><item><title>OxySure (OXYS) 3Q15 Results - 14 Consecutive Growth Quarters - Video News Alert on InvestmentPitch.com</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure--oxys--3q15-results---14-consecutive-growth-quarters---video-news-alert-on-investmentpitch-c,c9871124</link><guid isPermaLink="false">cision2045697</guid><description><![CDATA[Vancouver, British Columbia-- (Marketwired - November 20, 2015) - Medical device innovator, OxySure Systems (OTCQB: OXYS) announced results for the 3rd quarter 2015, reporting 14 consecutive quarters of growth.

InvestmentPitch.com has produced a "video news alert (http://www.investmentpitch.com/#sthash.d3I1QixO.dpuf)" which discusses the company’s financial results. If this link is not enabled, please visit www.InvestmentPitch.com and enter "OxySure" in the search box.

[image] (http://www.investmentpitch.com/#sthash.d3I1QixO.dpuf)

If you cannot view the video above, please visit:]]></description><pubDate>Fri, 20 Nov 2015 12:30:00 GMT</pubDate></item><item><title>OxySure (OXYS) Reports Third Quarter 2015 Financial Results with Annual Run Rate Approaching $5 Million</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure--oxys--reports-third-quarter-2015-financial-results-with-annual-run-rate-approaching--5-mill,c9868625</link><guid isPermaLink="false">cision2042009</guid><description><![CDATA[Company on Track to Reach $10 Million Run Rate and Breakeven in 2016
Frisco, Texas, November 17, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other medical solutions, today announced financial and operating results for the third quarter ended September 30, 2015.

Third Quarter 2015 Highlights:

  · Total revenue up 39% to $1,138,380 (3 months)
  · Total revenue up 52% to $2,809,553 (9 months)
  · Gross profit up 12%]]></description><pubDate>Tue, 17 Nov 2015 12:30:00 GMT</pubDate></item><item><title>OxySure (OXYS) To Host Third Quarter 2015 Financial Results Conference Call 4:15 pm ET on November 16, 2015</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure--oxys--to-host-third-quarter-2015-financial-results-conference-call-4-15-pm-et-on-november-1,c9865900</link><guid isPermaLink="false">cision2037704</guid><description><![CDATA[Frisco, Texas, November 12, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other medical solutions, today announced that it will hold a conference call at 4:15 pm ET on Monday, November 16, 2015 to discuss its financial results for the three and nine months ended September 30, 2015.

Mr. Julian Ross, CEO of OxySure, will host the conference call. To join the Audio Conference, please dial the phone number ten minutes prior to the start]]></description><pubDate>Thu, 12 Nov 2015 13:30:00 GMT</pubDate></item><item><title>OxySure (OXYS) Board Approves Name Change to OxySure Therapeutics, Inc.</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure--oxys--board-approves-name-change-to-oxysure-therapeutics--inc-,c9863218</link><guid isPermaLink="false">cision2033351</guid><description><![CDATA[Frisco, Texas, November 9, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other innovative medical solutions, today announced that its Board of Directors approved a change of the Company’s name to OxySure Therapeutics, Inc.

“The purpose of the name change is to better reflect the business and industry that we are in,” said Julian Ross, CEO of OxySure. “It also enhances the Company’s positioning as we march towards our]]></description><pubDate>Mon, 09 Nov 2015 13:00:00 GMT</pubDate></item><item><title>OxySure (OXYS) Files Lawsuit – Seeks Millions in Damages</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure--oxys--files-lawsuit---seeks-millions-in-damages,c9859369</link><guid isPermaLink="false">cision2027649</guid><description><![CDATA[FRISCO, TX -- (Marketwired – November 3, 2015) – OxySure Systems, Inc. (OTCQB: OXYS), (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other innovative medical solutions, announced today that the Company has filed a lawsuit against TEGNA Inc., WFAA T.V. Channel 8, Jobin Panicker, a reporter for WFAA T.V., The Redwine Law Firm PLLC, and Symone Redwine, an attorney at The Redwine Law Firm.

The lawsuit seeks millions in damages from Redwine for tortious interference]]></description><pubDate>Tue, 03 Nov 2015 13:00:00 GMT</pubDate></item><item><title>OxySure (OXYS) Marks Seven Years and Thousands of Lives Saved - Safely</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure--oxys--marks-seven-years-and-thousands-of-lives-saved---safely,c9854457</link><guid isPermaLink="false">cision2018865</guid><description><![CDATA[“If it wasn’t for this machine and what they did, our daughter may still be with us today but she wouldn’t be the Kylee we know.”

Mike Shea, father of Kylee Shea.
FRISCO, TX -- (MarketWired – October 26, 2015)

[image]According to the reporting of Matt Lauer of the Today Show, what could have been a tragic situation actually turned into a happy ending for middle school student Kylee Shea. Added NBC’s Lilia Luciano: “What happened to 12-year old Kylee Shea is something most parents wouldn’t even think is possible. Walking the halls of her school she suddenly collapsed, and without the]]></description><pubDate>Mon, 26 Oct 2015 11:30:00 GMT</pubDate></item><item><title>OxySure (OXYS) Provides Corporate Update</title><link>http://news.cision.com/oxysure-systems--inc-/r/oxysure--oxys--provides-corporate-update,c9852573</link><guid isPermaLink="false">cision2016385</guid><description><![CDATA[FRISCO, TX -- (Marketwired – October 22, 2015) – OxySure Systems, Inc. (OTCQB: OXYS), (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other innovative medical solutions, announced today the release of a corporate update as presented by OxySure's CEO Julian Ross.

Mr. Ross began the update by stating, "We are excited to provide this update to our shareholders, employees, suppliers and customers to report on our progress during the past several months and in 2015]]></description><pubDate>Thu, 22 Oct 2015 12:00:00 GMT</pubDate></item></channel></rss>